Cargando…

Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features

PURPOSE: Biomarkers that can accurately predict outcome in DLBCL patients are urgently needed. Radiomics features extracted from baseline [(18)F]-FDG PET/CT scans have shown promising results. This study aims to investigate which lesion- and feature-selection approaches/methods resulted in the best...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eertink, Jakoba J., Zwezerijnen, Gerben J. C., Cysouw, Matthijs C. F., Wiegers, Sanne E., Pfaehler, Elisabeth A. G., Lugtenburg, Pieternella J., van der Holt, Bronno, Hoekstra, Otto S., de Vet, Henrica C. W., Zijlstra, Josée M., Boellaard, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606052/ https://www.ncbi.nlm.nih.gov/pubmed/35925442 http://dx.doi.org/10.1007/s00259-022-05916-4

Ejemplares similares

(18)F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma
por: Eertink, Jakoba J., et al.
Publicado: (2021)

External validation: a simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data from DLBCL patients
por: Eertink, Jakoba J., et al.
Publicado: (2022)

Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor
por: Zwezerijnen, Gerben J. C., et al.
Publicado: (2022)

Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
por: Eertink, Jakoba J., et al.
Publicado: (2022)

Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index
por: Mikhaeel, N. George, et al.
Publicado: (2022)

An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients
por: Ferrández, Maria C., et al.
Publicado: (2023)

Combatting the effect of image reconstruction settings on lymphoma [(18)F]FDG PET metabolic tumor volume assessment using various segmentation methods
por: Ferrández, Maria C., et al.
Publicado: (2022)

Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements
por: Eertink, J. J., et al.
Publicado: (2021)

Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
por: Drees, Esther E. E., et al.
Publicado: (2022)

Sensitivity of an AI method for [(18)F]FDG PET/CT outcome prediction of diffuse large B-cell lymphoma patients to image reconstruction protocols
por: Ferrández, Maria C., et al.
Publicado: (2023)

Prognostic model using (18)F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
por: Driessen, Julia, et al.
Publicado: (2023)

Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis
por: Cysouw, Matthijs C. F., et al.
Publicado: (2017)

How I treat older patients with DLBCL in the frontline setting
por: Lugtenburg, Pieternella J., et al.
Publicado: (2023)

Optimizing Workflows for Fast and Reliable Metabolic Tumor Volume Measurements in Diffuse Large B Cell Lymphoma
por: Burggraaff, Coreline N., et al.
Publicado: (2020)

Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma
por: Eertink, J. J., et al.
Publicado: (2023)

No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study
por: Geerdes, Emma E., et al.
Publicado: (2023)

Convolutional neural networks for automatic image quality control and EARL compliance of PET images
por: Pfaehler, Elisabeth, et al.
Publicado: (2022)

Machine learning-based analysis of [(18)F]DCFPyL PET radiomics for risk stratification in primary prostate cancer
por: Cysouw, Matthijs C. F., et al.
Publicado: (2020)

DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set
por: Vrabac, Damir, et al.
Publicado: (2021)

Primary therapy and survival among patients with nodular lymphocyte‐predominant Hodgkin lymphoma: a population‐based analysis in the Netherlands, 1993–2016
por: Posthuma, Hidde L. A., et al.
Publicado: (2019)

Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands
por: Posthuma, Hidde L. A., et al.
Publicado: (2021)

PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability
por: Pfaehler, Elisabeth, et al.
Publicado: (2020)

Mitigation of noise-induced bias of PET radiomic features
por: Somasundaram, Ananthi, et al.
Publicado: (2022)

3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body (18)F-Fluorodeoxyglucose and (89)Zr-Rituximab PET Scans
por: de Vries, Bart M., et al.
Publicado: (2022)

Plausibility and redundancy analysis to select FDG‐PET textural features in non‐small cell lung cancer
por: Pfaehler, Elisabeth, et al.
Publicado: (2021)

Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis
por: Burggraaff, Coreline N., et al.
Publicado: (2018)

The immune checkpoint expression in the tumor immune microenvironment of DLBCL: Clinicopathologic features and prognosis
por: Ma, Jiajia, et al.
Publicado: (2022)

Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images
por: Jauw, Yvonne W. S., et al.
Publicado: (2018)

Predictive value of quantitative (18)F-FDG-PET radiomics analysis in patients with head and neck squamous cell carcinoma
por: Martens, Roland M., et al.
Publicado: (2020)

A systematic review and quality of reporting checklist for repeatability and reproducibility of radiomic features
por: Pfaehler, Elisabeth, et al.
Publicado: (2021)

Updating PET/CT performance standards and PET/CT interpretation criteria should go hand in hand
por: Boellaard, Ronald, et al.
Publicado: (2019)

Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics
por: Cysouw, M. C. F., et al.
Publicado: (2019)

Sensitivity of (18)F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer
por: Cysouw, Matthijs C. F., et al.
Publicado: (2019)

Repeatability of (18)F‐FDG PET radiomic features: A phantom study to explore sensitivity to image reconstruction settings, noise, and delineation method
por: Pfaehler, Elisabeth, et al.
Publicado: (2018)

Interobserver reproducibility of tumor uptake quantification with (89)Zr-immuno-PET: a multicenter analysis
por: Jauw, Yvonne W. S., et al.
Publicado: (2019)

Diffuse large B-cell lymphoma (DLBCL) with significant intravascular invasion. Close resemblance of its clinicopathological features to intravascular large B-cell lymphoma, but not to DLBCL-not otherwise specified
por: Itami, Hiroe, et al.
Publicado: (2021)

Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes
por: Lim, Taekyu, et al.
Publicado: (2011)

Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy
por: Lamure, Sylvain, et al.
Publicado: (2021)

The Immunology of DLBCL
por: Takahara, Taishi, et al.
Publicado: (2023)

P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS
por: Maas, Carolien, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dla62sngemub8a0dqt1tkc53fj